Profile

PhD, Queen's University Belfast
BS, Queen's University Belfast




DIVA: vanquishing acute viral infections by finding the TIPping point
03/01/2017 - 11/30/2018 (PI)
Department of Defense/DARPA


Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
06/01/2016 - 11/30/2018 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R01AI099100-05

Dissecting the pathogenesis of feline morbillivirus
03/11/2016 - 11/30/2018 (PI)
Zoetis, LLC


Generation of Predictive Models of Viral Pathogenesis
11/06/2015 - 09/30/2017 (Subcontract PI)
Battelle Memorial Institute/Pacific Northwest National Laboratory Department of Energy
DE-AC05-76RL01830

Investigating feline morbillivirus molecular epidemiology in cats in the North Eastern United States
08/26/2014 - 06/30/2016 (PI)
Zoetis, LLC


Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
06/01/2013 - 05/31/2016 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R01AI099100-03

Mapping the Adaption of Animal Morbilliviruses to Human Cells: Evolution, Structural Modelling and Prediction
09/30/2013 - 03/31/2016 (PI)
Department of Defense/DARPA


Illuminating the Cellular Tropism of measles Vaccine Viruses in Macaques: What is the Effect of Vaccination Route on Immunogenicity and Protection?
04/01/2010 - 08/31/2014 (PI)
Foundation for NIH


National Emerging Infectious Diseases Laboratories Operations
06/20/2012 - 07/31/2014 (Sub-Project Level Key Person)
PI: John R. Murphy, PhD
NIH/National Institute of Allergy & Infectious Diseases
3UC7AI070088-05S3

Multimodal Imaging of Antibody-Mediated Therapy During Acute Viral Encephalitides
06/06/2012 - 06/30/2013 (Co-Investigator)
PI: Katharine N. Bossart, PhD
NIH/National Institute of Allergy & Infectious Diseases
5R21AI101442-02



Title


Yr Title Project-Sub Proj Pubs
2024 Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization 5R01AI163011-03
2023 Pitt RBL 1UC7AI180311-01
2023 Operations Core 1UC7AI180311-01-9963
2023 Integrated Services Core 1UC7AI180311-01-9965
2023 Practices Core 1UC7AI180311-01-9964
2023 Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization 7R01AI163011-02
2022 Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research 3G20AI167405-01S1
2022 Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization 1R01AI163011-01A1
2021 Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research 1G20AI167405-01
2017 Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation 5R01AI099100-05 7
Showing 10 of 19 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Barbeau DJ, Albe JR, Nambulli S, Tilston-Lunel NL, Hartman AL, Lakdawala SS, Klein E, Duprex WP, McElroy AK. Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret. mSphere. 2020 10 28; 5(5).View Related Profiles. PMID: 33115835; PMCID: PMC7593599; DOI: 10.1128/mSphere.00798-20;
     
  2. Laksono BM, Fortugno P, Nijmeijer BM, de Vries RD, Cordisco S, Kuiken T, Geijtenbeek TBH, Duprex WP, Brancati F, de Swart RL. Measles skin rash: Infection of lymphoid and myeloid cells in the dermis precedes viral dissemination to the epidermis. PLoS Pathog. 2020 10; 16(10):e1008253. PMID: 33031460
     
  3. Rennick LJ, Nambulli S, Lemon K, Olinger GY, Crossland NA, Millar EL, Duprex WP. Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats. J Gen Virol. 2020 10; 101(10):1056-1068.View Related Profiles. PMID: 32723429
     
  4. Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, Delang L, Dohm E, Duprex WP, Falzarano D, Finch CL, Frieman MB, Graham BS, Gralinski LE, Guilfoyle K, Haagmans BL, Hamilton GA, Hartman AL, Herfst S, Kaptein SJF, Klimstra WB, Knezevic I, Krause PR, Kuhn JH, Le Grand R, Lewis MG, Liu WC, Maisonnasse P, McElroy AK, Munster V, Oreshkova N, Rasmussen AL, Rocha-Pereira J, Rockx B, Rodríguez E, Rogers TF, Salguero FJ, Schotsaert M, Stittelaar KJ, Thibaut HJ, Tseng CT, Vergara-Alert J, Beer M, Brasel T, Chan JFW, García-Sastre A, Neyts J, Perlman S, Reed DS, Richt JA, Roy CJ, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. Animal models for COVID-19. Nature. 2020 10; 586(7830):509-515. PMID: 32967005
     
  5. Hartman AL, Nambulli S, McMillen CM, White AG, Tilston-Lunel NL, Albe JR, Cottle E, Dunn MD, Frye LJ, Gilliland TH, Olsen EL, O'Malley KJ, Schwarz MM, Tomko JA, Walker RC, Xia M, Hartman MS, Klein E, Scanga CA, Flynn JL, Klimstra WB, McElroy AK, Reed DS, Duprex WP. SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts. PLoS Pathog. 2020 09; 16(9):e1008903.View Related Profiles. PMID: 32946524; PMCID: PMC7535860; DOI: 10.1371/journal.ppat.1008903;
     
  6. Kuhn JH, Adkins S, Alioto D, Alkhovsky SV, Amarasinghe GK, Anthony SJ, Avšic-Županc T, Ayllón MA, Bahl J, Balkema-Buschmann A, Ballinger MJ, Bartonicka T, Basler C, Bavari S, Beer M, Bente DA, Bergeron É, Bird BH, Blair C, Blasdell KR, Bradfute SB, Breyta R, Briese T, Brown PA, Buchholz UJ, Buchmeier MJ, Bukreyev A, Burt F, Buzkan N, Calisher CH, Cao M, Casas I, Chamberlain J, Chandran K, Charrel RN, Chen B, Chiumenti M, Choi IR, Clegg JCS, Crozier I, da Graça JV, Dal Bó E, Dávila AMR, de la Torre JC, de Lamballerie X, de Swart RL, Di Bello PL, Di Paola N, Di Serio F, Dietzgen RG, Digiaro M, Dolja VV, Dolnik O, Drebot MA, Drexler JF, Dürrwald R, Dufkova L, Dundon WG, Duprex WP, Dye JM, Easton AJ, Ebihara H, Elbeaino T, Ergünay K, Fernandes J, Fooks AR, Formenty PBH, Forth LF, Fouchier RAM, Freitas-Astúa J, Gago-Zachert S, Gao GF, García ML, García-Sastre A, Garrison AR, Gbakima A, Goldstein T, Gonzalez JJ, Griffiths A, Groschup MH, Günther S, Guterres A, Hall RA, Hammond J, Hassan M, Hepojoki J, Hepojoki S, Hetzel U, Hewson R, Hoffmann B, Hongo S, Höper D, Horie M, Hughes HR, Hyndman TH, Jambai A, Jardim R, Jiang D, Jin Q, Jonson GB, Junglen S, Karadag S, Keller KE, Klempa B, Klingström J, Kobinger G, Kondo H, Koonin EV, Krupovic M, Kurath G, Kuzmin IV, Laenen L, Lamb RA, Lambert AJ, Langevin SL, Lee B, Lemos ERS, Leroy EM, Li D, Li J, Liang M, Liú W, Liú Y, Lukashevich IS, Maes P, Marciel de Souza W, Marklewitz M, Marshall SH, Martelli GP, Martin RR, Marzano SL, Massart S, McCauley JW, Mielke-Ehret N, Minafra A, Minutolo M, Mirazimi A, Mühlbach HP, Mühlberger E, Naidu R, Natsuaki T, Navarro B, Navarro JA, Netesov SV, Neumann G, Nowotny N, Nunes MRT, Nylund A, Økland AL, Oliveira RC, Palacios G, Pallas V, Pályi B, Papa A, Parrish CR, Pauvolid-Corrêa A, Paweska JT, Payne S, Pérez DR, Pfaff F, Radoshitzky SR, Rahman AU, Ramos-González PL, Resende RO, Reyes CA, Rima BK, Romanowski V, Robles Luna G, Rota P, Rubbenstroth D, Runstadler JA, Ruzek D, Sabanadzovic S, Salát J, Sall AA, Salvato MS, Sarpkaya K, Sasaya T, Schwemmle M, Shabbir MZ, Shí X, Shí Z, Shirako Y, Simmonds P, Širmarová J, Sironi M, Smither S, Smura T, Song JW, Spann KM, Spengler JR, Stenglein MD, Stone DM, Straková P, Takada A, Tesh RB, Thornburg NJ, Tomonaga K, Tordo N, Towner JS, Turina M, Tzanetakis I, Ulrich RG, Vaira AM, van den Hoogen B, Varsani A, Vasilakis N, Verbeek M, Wahl V, Walker PJ, Wang H, Wang J, Wang X, Wang LF, Wèi T, Wells H, Whitfield AE, Williams JV, Wolf YI, Wú Z, Yang X, Yáng X, Yu X, Yutin N, Zerbini FM, Zhang T, Zhang YZ, Zhou G, Zhou X. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Arch Virol. 2020 Dec; 165(12):3023-3072.View Related Profiles. PMID: 32888050; PMCID: PMC7606449; DOI: 10.1007/s00705-020-04731-2;
     
  7. Xiang Y, Nambulli S, Xiao Z, Liu H, Sang Z, Duprex WP, Schneidman-Duhovny D, Zhang C, Shi Y. Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2. bioRxiv. 2020 Aug 25.View Related Profiles. PMID: 32869034; PMCID: PMC7457627; DOI: 10.1101/2020.08.24.264333;
     
  8. Klimstra WB, Tilston-Lunel NL, Nambulli S, Boslett J, McMillen CM, Gilliland T, Dunn MD, Sun C, Wheeler SE, Wells A, Hartman AL, McElroy AK, Reed DS, Rennick LJ, Duprex WP. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients. J Gen Virol. 2020 11; 101(11):1156-1169.View Related Profiles. PMID: 32821033; PMCID: PMC7879561; DOI: 10.1099/jgv.0.001481;
     
  9. Rijsbergen LC, Rennick LJ, Laksono BM, van Run PRWA, Kuiken T, Duprex WP, de Swart RL, de Vries RD. In vivo comparison of a laboratory-adapted and clinical-isolate-based recombinant human respiratory syncytial virus. J Gen Virol. 2020 10; 101(10):1037-1046.View Related Profiles. PMID: 32692644
     
  10. Klimstra WB, Tilston-Lunel NL, Nambulli S, Boslett J, McMillen CM, Gilliland T, Dunn MD, Sun C, Wheeler SE, Wells A, Hartman AL, McElroy AK, Reed DS, Rennick LJ, Duprex WP. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients. bioRxiv. 2020 Jun 22.View Related Profiles. PMID: 32607507; PMCID: PMC7325173; DOI: 10.1101/2020.06.19.154930;
     
Showing 10 of 128 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 18 publications over 10 distinct years, with a maximum of 4 publications in 2011

YearPublications
19951
20001
20022
20041
20062
20071
20081
20114
20123
20132
Contact for Mentoring:

Media Mentions
_